Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Viola Vitalis AB
AB
Active
Org 5568241177
Avestagatan 35, 163 53
Spånga
Manufacture of pharmaceutical preparations
·
NACE 2120
Est. 2010 · 15 years old
3 employees
Monitor
Share
Sweden
/
Companies
/
Manufacture of pharmaceutical preparations
/
Viola Vitalis AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
19M
14M
9M
5M
0M
2021: 6M
6M
2021
2022: 13M (+117% vs 2021)
13M
+117%
2022
2023: 15M (+15% vs 2022)
15M
+15%
2023
2024: 6M (-60% vs 2023)
6M
-60%
2024
2025: 6M (0% vs 2024)
6M
0%
2025
EBITDA
SEK millions
4M
3M
1M
-1M
-2M
2021: 0M
0M
2021
2022: 3M
3M
2022
2023: 1M (-67% vs 2022)
1M
-67%
2023
2024: -1M (-200% vs 2023)
-1M
-200%
2024
2025: 1M (+200% vs 2024)
1M
+200%
2025
Income statement
SEK thousands
Item
2025
2024
2023
2022
2021
Revenue
5 801
6 212
15 044
12 744
5 844
Staff expenses
−696
—
—
—
—
EBITDA
596
−1 337
1 260
2 915
141
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
596
−1 337
1 260
2 915
141
Net financials
−1 117
−4 656
−8 984
−4 872
−1 643
Profit before tax
−520
−4 286
−3 549
−1 152
−729
Tax
−0
−0
−164
−432
−0
Net profit
−520
−4 286
−3 713
−1 584
−729
Balance sheet
SEK thousands
Item
2025
2024
2023
2022
2021
Total assets
1 826
2 051
7 647
19 999
6 594
Equity
−4 292
−4 772
−2 486
327
312
Long-term debt
4 047
4 842
5 119
5 269
4 155
Short-term debt
2 071
1 981
4 434
13 823
2 047
Total debt
6 118
6 823
9 553
19 092
6 202
Financial ratios
5-year trend
EBITDA margin
10,3 %
This company
15,8 %
Market median
This company
Market median
35% below market
2021
2025
Equity ratio
−235,1 %
This company
38,2 %
Market median
This company
Market median
715% below market
2021
2025
Return on equity
—
This company
18,4 %
Market median
This company
Market median
2021
2025
Net profit margin
−9,0 %
This company
8,1 %
Market median
This company
Market median
211% below market
2021
2025
Asset turnover
3,18×
This company
1,12×
Market median
This company
Market median
184% above market
2021
2025
Debt / equity
—
This company
0,62×
Market median
This company
Market median
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
More on Viola Vitalis AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
